Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Ménétrier's disease (MD) is a rare hypertrophic gastropathy marked by enlarged gastric folds, excessive mucus secretion, and protein-losing enteropathy. We present the case of a 25-year-old man initially hospitalized with severe chronic anemia, which revealed a rare and challenging form of MD. The patient reported persistent epigastric pain, vomiting, and recurrent hematemesis. Biological workup showed profound hypoalbuminemia (20 g/L) and microcytic anemia (Hb 5.8 g/dL, ferritin 3 ng/mL). Abdominal CT and upper endoscopy revealed massive polypoid thickening of the gastric fundus with cerebral-like folds and friable polypoid lesions. Histology confirmed foveolar hyperplasia with glandular atrophy, consistent with MD, in the absence of infection. Despite supportive care, the patient experienced recurrent gastrointestinal bleeding and transfusion-dependent anemia, ultimately requiring total gastrectomy. Surgery led to a significant improvement in symptoms and nutritional status. The case report emphasizes the diagnostic complexity and challenges of managing MD, particularly in patients with severe presentations. The successful outcome following total gastrectomy underscores the importance of considering surgical options in selected cases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375279PMC
http://dx.doi.org/10.7759/cureus.88724DOI Listing

Publication Analysis

Top Keywords

total gastrectomy
12
chronic anemia
8
case report
8
challenging form
8
ménétrier's disease
8
anemia total
4
gastrectomy case
4
report challenging
4
form ménétrier's
4
disease ménétrier's
4

Similar Publications

Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting toxicity associated with oxaliplatin-based chemotherapy in gastric cancer patients. Recent studies suggest that high-dose intravenous selenium may exert neuroprotective effects in patients receiving platinum-based chemotherapy.

Methods: This pilot study analyzed patients with stage III gastric adenocarcinoma who underwent gastrectomy between January and December 2024.

View Article and Find Full Text PDF

Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.

View Article and Find Full Text PDF

Background: Hypocalcemia is common after cervical procedures. Patients who have undergone Roux-en-Y gastric bypass (RYGB) experience increased risk for post-thyroidectomy hypocalcemia. This association has not been elucidated for nonbariatric operations that bypass the duodenum.

View Article and Find Full Text PDF

Gastrosplenic fistula is a rare complication, most often secondary to gastric or splenic lymphoma. Severe gastrosplenic fistula can cause life-threatening upper gastrointestinal bleeding, making early diagnosis and intervention critical for a favorable prognosis. Currently, surgical intervention remains the primary treatment; however, outcomes are often suboptimal.

View Article and Find Full Text PDF

Background: The development of cholelithiasis and its subsequent complications are a known risk after vertical sleeve gastrectomy (VSG) due to rapid weight loss. Although controversial, concomitant cholecystectomy (CCY) at the time of bariatric surgery has been proposed, with multiple studies investigating simultaneous CCY with Roux-en-Y gastric bypass. Despite VSG being the most commonly performed bariatric surgery in the United States (US) and globally, few studies have investigated the simultaneous VSG and CCY.

View Article and Find Full Text PDF